Targeted sequencing identifies many potentially actionable mutations in melanomas - 09/05/15
Nathaniel Slater, University of North Carolina School of Medicine, Chapel Hill, NC, United States; Edith Bowers, MD, PhD, University of North Carolina School of Medicine, Chapel Hill, NC, United States; Joel Parker, PhD, University of North Carolina School of Medicine, Chapel Hill, NC, United States; Nirali Patel, MD, University of North Carolina School of Medicine, Chapel Hill, NC, United States; David Eberhard, MD, PhD, University of North Carolina School of Medicine, Chapel Hill, NC, United States; Shelton Earp, MD, University of North Carolina School of Medicine, Chapel Hill, NC, United States; David Ollila, MD, University of North Carolina School of Medicine, Chapel Hill, NC, United States; Stergios Moschos, MD, University of North Carolina School of Medicine, Chapel Hill, NC, United States; Neil Hayes, MD, MPH, University of North Carolina School of Medicine, Chapel Hill, NC, United States; Nancy Thomas, MD, PhD, University of North Carolina School of Medicine, Chapel Hill, NC, United States
Le texte complet de cet article est disponible en PDF.| Commercial support: None identified. |
Vol 72 - N° 5S1
P. AB176 - mai 2015 Retour au numéro
Article précédent
- Study of mutations of CDKN2A - MITF in patients with familial melanoma in Chilean population
- The correlation of skin color with dermoscopic nevus patterns in a Queensland high risk melanoma cohort
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?